None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients aged 19 years or older and under 80 years. Patients scheduled to undergo laparoscopic major hepatectomy for liver cancer. Major hepatectomy is defined as the resection of three or more liver segments or non-anatomical resection of 30% or more of the liver. Patients must be able to provide written informed consent to participate in the clinical trial, understand the procedures of the study, and be capable of appropriately completing patient-reported questionnaires.
Exclusion criteria
Exclusion criteria: Patients meeting any of the following criteria will be excluded from the study: American Society of Anesthesiologists (ASA) physical status of 4 or higher. Patients with chronic obstructive pulmonary disease (COPD). Patients with a Child-Turcotte-Pugh (CTP) score of C. Patients with arrhythmia. Patients deemed unsuitable for participation in the clinical trial based on the investigator’s or study coordinator’s judgment. Cases where the procedure is converted to open surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Introperative blood loss | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative pulmonary complications (atelectasis and pneumonia);Postoperatvie laboratory data ;Surgeon and anesthesiologist satisfaction scale (rated from 0 = easy to 10 = difficult) | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center